The peptide targets involved in the pathogenesis of T1D are subject of current investigation and include preproinsulin and glutamate decarboxylase (GAD) derived peptides, as well as misfolded or modified proteins [10,48,49,50,51,52]. This evidence concerns the gene GAD1 and type 1 diabetes mellitus.